• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT LIBRARY
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES

MSKai Spine Imaging Software Receives FDA 510(k) Clearance for Clinical Use

May 23, 2025 By SPINEMarketGroup

JACKSON, Miss., May 22, 2025 /PRNewswire/ — MSKai, an advanced image identification and post-processing software platform for spine imaging, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), authorizing its use by physicians and radiologists for lumbar spine MRI analysis. The FDA determined that MSKai is substantially equivalent to legally marketed devices, allowing it to be marketed under the general controls of the Federal Food, Drug, and Cosmetic Act.

“The FDA’s decision confirms that MSKai meets rigorous safety and performance standards as a spine imaging tool,” said Chip Wade, Ph. D., chief operating officer at MSKai. “We’re proud to deliver a product that gives healthcare professionals enhanced capabilities in lumbar spine analysis while reinforcing the central role of expert clinical judgement.”

MSKai is a powerful tool that assists qualified medical professionals in the evaluation of previously acquired T2-weighted lumbar spine MRIs. The software enables users to perform anatomy segmentation, labeling, measurement and export of quantitative and qualitative results into customizable reports. By delivering objective, repeatable spine measurements, MSKai supports greater efficiency and consistency in clinical imaging workflows.

MSKai is not a diagnostic device and does not provide or recommend any medical diagnosis or treatment. Instead, it serves as a decision-support tool that offers clear, repeatable insights for users trained in medical imaging. Users are responsible for confirming preferences, verifying automated measurements, and finalizing reports in accordance with clinical best practices.

For more information about MSKai, please visit MSKai.ai.

About MSKai
MSKai, LLC develops artificial intelligence-based technology (AI) to be used to improve patient care and surgical outcomes and to support pre-surgery authorizations for patients. The current software identifies, measures, and classifies spinal anatomy and pathologies from a quantitative and qualitative standpoint within seconds. For more information about MSKai, please visit MSKai.ai.

SOURCE MSKai

Filed Under: FDA APPROVED, NEWS Tagged With: 2025

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMMED
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
logo paradigm spine
syntropiq logo

POPULAR POST LAST 90 DAYS

  • BROCHURES
  • PRODUCT LIBRARY
  • 2025 Spine Product Launches and Trends: Where is the…
  • Medical Device Correction Addresses Loss of Lordosis…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • Medtronic Named in Florida Lawsuit Over Alleged…
  • Johnson & Johnson Follows in Zimmer Biomet’s…
  • 2025 Update: Posterior Cervical Spine Systems Market…
  • COMPANIES
  • First CD Horizon™ ModuLeX™ Deformity Surgery in…
  • Top Six Spine Industry Milestones in 2025
  • Globus Medical Reports Preliminary Record Fourth…
  • Seven Leading Augmented (AR) and Extended Reality…
  • Did Globus Medical’s Q3 Performance Reinforce Market…
  • The End of an Era: The Former LDR Medical Site in…
  • Medtronic Korea Launches Kanghui, a New…
  • ATEC Announces Select Preliminary Financial Results…
  • Scientists Develop AxioMed Spinal Disc Replacement…
  • LAST 5 VIDEOS PUBLISHED

    1. REVEL™-S: Globus Medical
    2. EXCENDER CG Bio
    3. Spineology: New OptiMesh HA Nano
    4. Taiwan OrthopedicBiotechnology:  Caduceus 
    5. Augmedics: Meet X2

     

     

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal

    Copyright © 2026 · SPINEMarketGroup